Article PubMed Google Scholar Download references Related Articles Obesity drugs: huge study identifies new health risks Why do obesity drugs seem to treat so many other ailments
Amgens Role and Responsibilities As a leading biopharmaceutical company, Amgen manages the full lifecycle of MariTide, from research to potential commercialization: Research & Development: Conduct preclinical and multi-phase clinical trials to ensure efficacy, safety, and optimal dosing
Under normal development conditions, TOR is active and phosphorylates the Autophagy-Related (Atg) 13 protein several times
Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium
RSL3 inhibits mTOR signaling in thyroid cancer cells The mTOR signaling pathway has recently been implicated in counteracting ferroptosis by regulating ROS production 20 , therefore, it was important to examine the effects of RSL3 on mTOR signaling pathway and its downstream proteins and whether inactivation of mTOR pathway signaling will occur in thyroid cancer cells with GPX4 inhibition
90% CI, 0.631.71)